Skip to main content
SpringerLink
Log in

Compounds with Antibacterial Activity

  • Chapter
Bioactive Egg Compounds

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aguilera O, Quiros LM, Fierro JF (2003) Transferrins selectively cause ion efflux through bacterial and artificial membranes. FEBS Letters 548:5–10.

    Article  PubMed  Google Scholar 

  • Andrews SC, Robinson AK, Rodriguez-Quinones F (2003). Bacterial iron homeostasis. FEMS microbiology reviews. 27:215–237.

    Article  PubMed  Google Scholar 

  • Antonini E (1977) Composition for the treatment of bacterial-intestinal infections, US patent no. °4029771, function in weanling piglets. J Vet Med Sci 55:899–900.

    Google Scholar 

  • Araki S, Suzuki M, Fujimoto M (1992) Enhanced resistance to bacterial infections in mice by oral administration of an active egg white product. J Vet Med Sci 54:1055–1056.

    PubMed  Google Scholar 

  • Asakura K, Kojima T, Shirasaki H, Kataura A (1990) Evaluation of the effects of antigen-specific immunotherapy on chronic sinusitis in children with allergy. Auris Nasus Larynx 17:33–38.

    PubMed  Google Scholar 

  • Atrih A, Bacher G, Allmaier G, Williamson MP, Foster SJ (1999) Analysis of peptidoglycan structure from vegetative cells of Bacillus subtilis 168 and role of PBP 5 in peptidoglycan maturation. J Bacteriol 181:3956–3966.

    PubMed  Google Scholar 

  • Babini GS, Livermore DM (2000) Effect of conalbumin on the activity of Syn2190, a 1, 5dihydroxy-4-pyridon monobactam inhibitor of AmpC ß-lactamases. J Antimicrobial Chemotherapy 45: 105–109.

    Article  Google Scholar 

  • Baron F, Gautier M, Brule G (1997) Factors involved in the inhibition of growth of Salmonella enteritidis in liquid egg white. J Food Prot 60:1318–1323.

    Google Scholar 

  • Bateman KS, Huang K, Anderson S, Lu W, Qasim MA, Laskowski M Jr, James MN (2001) Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I. J Mol Biol 305:839–49.

    Article  PubMed  Google Scholar 

  • Bera A, Herbert S, Jakob A, Vollmer W, Götz F (2005) Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 55:778–787.

    Article  PubMed  Google Scholar 

  • Birk Y, Khalef S, Jibson MD (1983) Purification and properties of protease F, a bacterial enzyme with chymotrypsin and elastase specificities. Arch Biochem Biophys 225:4517.

    Article  Google Scholar 

  • Blankenvoorde MF, Van't Hof W, Walgreen-Weterings E, van Steenbergen TJ, Brand HS, Veerman EC, Nieuw Amerongen AV (1998) Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol Chem 379:1371–1375.

    PubMed  Google Scholar 

  • Das L, Datta N, Bandyopadhyay S, Das PK (2001) Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol 166:4020–4028.

    PubMed  Google Scholar 

  • De Douder C, Morias J (1974) On lysozyme therapy. I. Lysozyme tablets in treatment of some localized and generalized viral skin diseases. Medickon 3:19–20.

    Google Scholar 

  • Düring K, Porsch P, Mahn A, Brinkmann O and Gieffers W (1999). The non-enzymatic microbicidal activity of lysozymes. FEMS Letters 449:93–100.

    Google Scholar 

  • Ebina T, Tsukada K (1991) Protease inhibitors prevent the development of human rotavirus-induced diarrhea in suckling mice. Microbiol Immunol 35:583–588.

    PubMed  Google Scholar 

  • Garibaldi JA (1970) Role of microbial iron transport compounds in the bacteria spoilage of eggs. Appl Microbiol 20:558–560.

    PubMed  Google Scholar 

  • Gavrilenko TI, Siurin SA, Lolaeva LT, Sauchenko VM (1992) The characteristics of lysozyme and carbenicillin action on the clinico-immunological status of patients with chronic bronchitis Vrach Delo 8:42–45.

    Google Scholar 

  • Henskens YMC, Veerman ECI, Nieuw Amerongen AV (1996) Cystatins in health and disease. Biol Chem Hoppe-Seyler 377:71–86.

    PubMed  Google Scholar 

  • Ibrahim HR, Yamada M, Matsushita K, Kobayashi, Kato A (1994). Enhanced bactericidal action of lysozyme to Escherichia coli by inserting a hydrophobic pentapeptide into its terminus. J Biol Chem 269:5059–5063.

    PubMed  Google Scholar 

  • Ibrahim HR, Higashiguchi S, Juneja LR, Kim M, Yamamoto T (1996) A structural phase of heat-denatured lysozyme with novel antimicrobial action. J Agric Food Chem 44:1416–1423.

    Article  Google Scholar 

  • Ibrahim HR, Sugimoto Y, Aoki T (2000) Ovotransferrin antimicrobial peptide (OTAP-92) kills bacteria through a membrane damage mechanism. Biochim Biophys Acta 1523:196–205.

    PubMed  Google Scholar 

  • Ibrahim HR, Thomas U, Pellegrini A (2001) A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. J Biol Chem 276:43767–43774.

    Article  PubMed  Google Scholar 

  • Ibrahim HR, Aoki T, Pellegrini A (2002) Strategies for new antimicrobial proteins and peptides: lysozyme and aprotinin as model molecules. Curr Pharm Design 8:671–693.

    Article  Google Scholar 

  • Johnson EA (1994) Egg white lysozyme as a preservative for use in foods. In: Sim JS, Nakai S (eds) Egg uses and processing technologies. CAB, Wallingford. UK, pp 177–191.

    Google Scholar 

  • Kato T, Imatani T, Minaguchi K, Saitoh E, Okuda K (2002) Salivary cystatins induce interleukin-6 expression via cell surface molecules in human gingival fibroblasts. Mol Immunol 39: 423–30.

    Article  PubMed  Google Scholar 

  • Korant BD, Towatari T, Ivanoff L, Petteway S Jr, Brzin J, Lenarcic B, Turk V (1986) Viral therapy prospects for protease inhibitors. J Cell Biochem 32:91–95.

    Article  PubMed  Google Scholar 

  • Laible NJ Germain GR (1985) Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin. Infect Immun 48:720–728.

    PubMed  Google Scholar 

  • Maruo K, Akaike T, Ono T, Maeda H (1998) Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist. Infect Immun 66:866–869.

    PubMed  Google Scholar 

  • Masschalck B, Deckers D, Michiels CW (2002) Lytic and nonlytic mechanism of inactivation of gram-positive bacteria by lysozyme under atmospheric an high hydrostatic pressure. J Food Prot 65:1916–1923.

    PubMed  Google Scholar 

  • Matrosovich M, Zhou N, Kawaoka Y, Webster R (1999) The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J Virol 73:1146–55.

    PubMed  Google Scholar 

  • Matsumoto K (2004) Role of bacterial proteases in pseudomonal and serratial keratitis. Biol Chem 385:1007–1016.

    Article  PubMed  Google Scholar 

  • Mine Y, Ma F, Lauriau S (2004) Antimicrobial peptides released by enzymatic hydrolysis of hen egg white lysozyme. J Agric Food Chem 52:1088–1094.

    Article  PubMed  Google Scholar 

  • Miyagawa S, Nishino N, Kamata R, Okamura R, Maeda H (1991) Effects of protease inhibitors on growth of Serratia marcescens and Pseudomonas aeruginosa. Microb Pathog 11:137–141.

    Article  PubMed  Google Scholar 

  • Miyake M (2000) Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography. Anal Biochem 281:202–208.

    Article  PubMed  Google Scholar 

  • Molla A, Matsumura Y, Yamamoto T, Okamura R, Maeda H (1987) Pathogenic capacity of proteases from Serratia marcescens and Pseudomonas aeruginosa and their suppression by chicken egg white ovomacroglobulin. Infect Immun 55:2509–2517.

    PubMed  Google Scholar 

  • Murayama T, Amitani R, Ikegami Y, Nawada R, Lee WJ, Kuze F (1996) Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur Respir J 9:293–300.

    Article  PubMed  Google Scholar 

  • Nakagawa J, Osame S, Ichijo S, Araki S, Kimura M (1993) Effects of active egg white product on neutrophil function in calves. J Vet Med Sci 55:259–263.

    PubMed  Google Scholar 

  • Neilands JB (1995) Sidephores: structure and function of microbial iron transport compounds. J Biol Chem 270:26723–26726.

    PubMed  Google Scholar 

  • Pellegrini A (2003) Antimicrobial peptides from food proteins. Current Pharm Des 9:1225–1238.

    Article  Google Scholar 

  • Samuelson KJ, Rupnow JH, Froning GW (1985) The effect of lysozyme and ethylenediaminetetraacetic acid on Salmonella on broiler parts. Poult Sci 64:1488–1490.

    PubMed  Google Scholar 

  • Sava G (1996) Pharmacological aspects and therapeutic applications of lysozymes. EXS 75:433–449.

    PubMed  Google Scholar 

  • Serveau C, Lalmanach G, Juliano MA, Scharfstein J, Juliano L, Gauthier F (1996) Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. Biochem J 313:951–956.

    PubMed  Google Scholar 

  • Tenovuo J, Lumikari M, Soukka T (1991) Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proc Finn Dent Soc 87:197–208.

    PubMed  Google Scholar 

  • Tsuge Y, Shimoyamada M, Watanabe K (1996) Binding of egg white proteins to viruses. Biosci Biotechnol Biochem. 60:1503–1504.

    Article  PubMed  Google Scholar 

  • Valenti P, Visca P, Antonini G, Orsi N (1986). Interaction between lactoferrin and ovotransferrin and Candida cells. FEMS Microbiol Lett 33:271–275.

    Article  Google Scholar 

  • Yolken RH, Willoughby R, Wee SB, Miskuff R, Vonderfecht S (1987) Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J Clin Invest 79:148–154.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Agrocampus Rennes, INRA, UMR 1253 Sciences et Technologie, du Lait et de l'Oeuf, 65 rue de Saint brieuc, F-35000, Rennes, France

    Florence Baron

  2. INRA, HR 83 Recherches Avicoles, F-37380, Nouzilly, France

    Sophie Réhault

Authors
  1. Florence Baron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie Réhault
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biochemistry and Food Chemistry, University of Turku, 20014, Turku, Finland

    Rainer Huopalahti

  2. Mercedes Ramos: Instituto de Fermentaciones Industriales (CSIC), Juan de la Cierva 3, 28006, Madrid, Spain

    Rosina López-Fandiño

  3. UR1268 Biopolymères Interactions Assemblages, INRA, F-44316, NANTES, France

    Marc Anton

  4. Institut für Pharmakologie und Toxikologie, Charité-Universitätsmedizin Berlin, Dorotheenstr. 94, 10117, Berlin, Germany

    Rüdiger Schade

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Baron, F., Réhault, S. (2007). Compounds with Antibacterial Activity. In: Huopalahti, R., López-Fandiño, R., Anton, M., Schade, R. (eds) Bioactive Egg Compounds. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-37885-3_23

Download citation

Publish with us

Policies and ethics

Search

Navigation